Aborted sudden cardiac death in a young male with rheumatoid arthritis

Narae Kim1, Sang-Ho Cho2, In-Ho Yang1

  • 1Department of Cardiology, Kyung Hee University Hospital, Seoul, South Korea.

Insights

Rheumatoid arthritis (RA) significantly increases the risk of coronary artery disease (CAD), even in young adults. This case highlights RA as a potential major risk factor for severe CAD, including chronic total occlusion (CTO), despite treatment.

Area of Science:

  • Cardiology
  • Rheumatology
  • Vascular Biology

Background:

  • Rheumatoid arthritis (RA) is a known risk factor for coronary artery atherosclerosis, comparable to diabetes and hypertension.
  • Coronary artery disease (CAD), particularly chronic total occlusion (CTO), is uncommon in young individuals.
  • RA is associated with increased plaque vulnerability and prothrombotic states.

Observation:

  • A 26-year-old male with a 6-year history of RA presented with aborted sudden cardiac death.
  • The patient had no cardiovascular risk factors other than RA.
  • Multimodal evaluation revealed severe ischemic heart failure (HF) due to recent myocardial ischemia with CTO.

Findings:

  • Despite RA treatment, the patient developed severe HF with CTO, indicating RA's potent role in CAD progression.
  • This case underscores the potential for RA to be a primary driver of severe CAD in young patients.
  • RA's association with vulnerable plaques and prothrombotic tendencies may contribute to CTO development.

Implications:

  • RA should be considered a significant risk factor for CAD, including CTO, in young populations.
  • Current RA treatments may not fully mitigate the cardiovascular risk in all patients.
  • Further research is needed to understand and manage RA-associated cardiovascular complications, especially CTO in young adults.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
891
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391